• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HEARTWARE, INC HEARTWARE® VENTRICULAR ASSIST SYSTEM; CIRCULATORY ASSIST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HEARTWARE, INC HEARTWARE® VENTRICULAR ASSIST SYSTEM; CIRCULATORY ASSIST SYSTEM Back to Search Results
Catalog Number 1103
Device Problems Cut In Material (2454); Connection Problem (2900)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/14/2014
Event Type  malfunction  
Event Description
It was reported that a patient reported electrical fault alarms.A controller exchange was completed with no resolution of alarms.The patient indicated that he had accidentally cut the driveline while doing a dressing change.It was also reported that log files confirmed the issue with the patient's driveline.A temporary pump stop was required for repair.This procedure was completed in the or and the patient tolerated the repair procedure well.
 
Manufacturer Narrative
The site has indicated that the pump remains implanted, therefore it will not be returned.Device was used for treatment, not diagnosis.Ifu includes: perform exit site care every 24-48 hours using an antiseptic cleansing agent, such as a diluted chlorhexidine scrub solution.Following aseptic cleansing, rinse and dry the site to avoid tissue injury.Aseptic technique should be followed anytime the dressing is removed and the exit site is exposed, inspected, dressed or handled.When performing exit site care, be sure to wear a cap, mask and sterile gloves.Always examine the driveline for evidence of tears, punctures or breakdown of any of the material during exit site dressing changes.Driveline damage may affect heartware® system performance.Perform exit site care every 24-48 hours using an antiseptic cleansing agent, such as a diluted chlorhexidine scrub solution.Following aseptic cleansing, rinse and dry the site to avoid tissue injury.Aseptic technique should be followed anytime the dressing is removed and the exit site is exposed, inspected, dressed or handled.Product remains implanted.
 
Manufacturer Narrative
The hvad is used for treatment not diagnosis.It was reported that the patient accidentally cut through the driveline wires and began getting "electrical fault" alarms.The log files were sent to the manufacturer, which confirmed the issue with the patient's driveline.Representatives from the manufacturer traveled to the site to evaluate the driveline and confirmed superficial sheath damage and exposed damaged driveline wires, resulting in a sheath repair and splice procedure, respectively.There was no issue getting the pump to restart and the patient tolerated the procedure well.The root cause for "driveline wire damage" is improper handling/misuse by the user.The ventricular assist system is indicated for use as a bridge to cardiac transplantation in patients who are at risk of death from refractory end-stage left ventricular heart failure.The system is designed for in-hospital and out-of-hospital settings, including transportation.The instructions for use and patient manual outline the steps for handling and properly connecting power sources, including ensuring proper alignment, as well as instructions not to twist or force connections together in order to prevent damages.It is outlined to inspect the power connections and pins once a week, one at a time when changing the power source.Additionally there is a warning to keep spare, fully charged batteries and back up controller available at all time with a warning to switch to the back-up controller if there is a controller failure the steps for exchange of devices are also outlined.It further warns that damaged equipment should be reported to the manufacturer and inspected.Heartware is submitting this report as a result of remediation activities related to fda warning letter fla-14-14, dated june 2, 2014, and pursuant to the provisions of 21 cfr part 803.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTWARE® VENTRICULAR ASSIST SYSTEM
Type of Device
CIRCULATORY ASSIST SYSTEM
Manufacturer (Section D)
HEARTWARE, INC
14400 nw 60th avenue
miami lakes FL 33014 3105
Manufacturer (Section G)
HEARTWARE, INC
14400 nw 60th avenue
miami lakes FL 33014 3105
Manufacturer Contact
tatyana chorny
14400 nw 60th avenue
miami lakes, FL 33014-3105
3053641476
MDR Report Key4333927
MDR Text Key18798269
Report Number3007042319-2014-01323
Device Sequence Number1
Product Code DSQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,health professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/17/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/16/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/29/2016
Device Catalogue Number1103
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received12/17/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/28/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age54 YR
-
-